Results 11 to 20 of about 1,127,916 (265)

Autofluorescence-Raman Spectroscopy for Ex Vivo Mapping Colorectal Liver Metastases and Liver Tissue [PDF]

, 2023
Introduction: Identifying colorectal liver metastases (CRLM) during liver resection could assist in achieving clear surgical margins, which is an important prognostic variable for both disease-free and overall survival.
Dusanjh, Palminder Kaur, Harwood, Andrew, Mukherjee, Abhik, Dhanwant Gomez, Palminder Kaur Dusanjh, Abhik Mukherjee, Boitor, Radu, Christopher Corden, Ioan Notingher, Radu Boitor, Corden, Christopher, Notingher, Ioan, Gomez, Dhanwant, Andrew Harwood   +13 more
core   +1 more source

Total-liver-volume perfusion CT using 3-D image fusion to improve detection and characterization of liver metastases [PDF]

, 2008
The purpose of this study was to evaluate the feasibility of a totalliver- volume perfusion CT (CTP) technique for the detection and characterization of livermetastases.
Cornelis van Kuijk, van Waesberghe, Jan, Meijer, Sybren, Weide, Lineke van der, Sybren Meijer, van Kuijk, C., van den Tol, Petrousjka, Lineke van der Weide, van den Tol, M.P., van der Weide, L., Meijer, S., van der Weide, Lineke, Meijerink, Martijn, Martijn R. Meijerink, Jan Hein T. M. van Waesberghe, Meijerink, M.R., van Waesberghe, J.H.T.M., Kuijk, Cornelis van, Petrousjka van den Tol, Waesberghe, Jan van, Tol, Petrousjka van den   +20 more
core   +1 more source

What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up [PDF]

, 2010
Background: During the last two decades, resection of colorectal liver metastases (CLM) in selected patients has become the standard of care, with 5-year survival rates of 25-58%.
Parks, Rowan W.; id_orcid, Aldrighetti, Luca, Garden, O. James, Parks, Rowan W., Bodingbauer, Martin, Wigmore, Stephen J., Castillo, Federico, Ferla, Gianfranco, Pulitano, Carlo   +8 more
core   +1 more source

First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI) [PDF]

, 2012
The objective of this pilot clinical study was to assess the safety, technical feasibility, pharmacokinetic (PK) profile and tumour response of DC Bead™ with irinotecan (DEBIRI™) delivered by intra-arterial embolisation for the treatment of metastatic ...
Hammerstingl, Renate Maria, Mack, Martin G., Gallus, Christof, Eichler, Katrin, Gruber-Rouh, Tatjana, Vogl, Thomas J., Zangos, Stephan   +6 more
core   +1 more source

The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation [PDF]

, 2014
Background: Many deaths from cancer are caused by metastatic burden. Prognosis and survival rates vary, but survival beyond 5 years of patients with untreated metastatic disease in the liver is rare.
Breen, D., George, S., Joanna Picot, Steve George, Colquitt, Jillian, Mendes, Diana, Emma Loveman, Primrose, John, Clegg, Andrew J., Picot, J., John Primrose, Cunningham, David, Andrew J Clegg, Ruters, Theo, Theo Ruers, Colquitt, J.L., Cunningham, D., Moore, E., Ruers, T., Jones, Jeremy, Jeremy Jones, Picot, Joanna, Breen, David J., Jillian L Colquitt, Primrose, J.N., Clegg, Andrew, Graeme Poston, Loveman, Emma, Emily Moore, Moore, Emily, Diana Mendes, David J Breen, Poston, G., Poston, Graeme, George, Steve, David Cunningham   +35 more
core   +1 more source

Liver Metastases [PDF]

, 2021
Liver metastases are commonly detected in a range of malignancies including colorectal cancer (CRC), pancreatic cancer, melanoma, lung cancer and breast cancer, although CRC is the most common primary cancer that metastasizes to the liver.
Pawlik, Timothy M., Brodt, Pnina, Clavien, Pierre-Alain, Muschel, Ruth J., Parks, Rowan W; id_orcid, Endo, Itaru, de Santibanes, Eduardo, Tsilimigras, Diamantis I., D'Angelica, Michael, Doyle, Majella   +9 more
core   +1 more source

Can localised 19F magnetic resonance spectroscopy pharmacokinetics of 5FU in colorectal metastases predict clinical response? [PDF]

, 2010
Background 5-Fluorouracil remains widely used in colorectal cancer treatment more than 40 years after its development. 19F magnetic resonance spectroscopy can be used in vivo to measure 5FU’s half-life and metabolism to cytotoxic fluoronucleotides ...
Griffiths, John R., Ladroue, Christophe, Lofts, F, Lofts, Fiona, Griffiths, JR, John R. Griffiths, Marion Stubbs, Stubbs, Marion, Franklyn A. Howe, Fiona Lofts, McIntyre, DJ, Ladroue, C, Howe, FA, Howe, Franklyn A., McIntyre, Dominick J. O., Dominick J. O. McIntyre, Stubbs, M, Christophe Ladroue   +17 more
core   +1 more source

Phosphorylated transducer and activator of transcription-3 (pSTAT3) immunohistochemical expression in paired primary and metastatic colorectal cancer

Translational Oncology, 2021
Background: Signal Transducer and Activator of Transcription-3 (STAT3) mediates cellular functions. We assessed the IHC expression of phosphorylated STAT3 (pSTAT3) in paired primary tumors and liver metastases in patients with advanced stage colorectal ...
Esmeralda C. Marginean, Joanna Gotfrit, Horia Marginean, Daniel W. Yokom, Justin J. Bateman, Manijeh Daneshmand, Shelly Sud, Allen M. Gown, Derek Jonker, Timothy Asmis, Rachel A. Goodwin   +10 more
doaj   +1 more source

Metastatic breast cancer patients with lung or liver metastases should be distinguished before being treated with fulvestrant

Cancer Medicine, 2019
Background Endocrine therapy is the preferred treatment for patients with hormone receptor ‐positive metastatic breast cancer (MBC). While visceral metastasis is a negative prognostic factor, few studies have distinguished between the prognoses of ...
Min He, Jun‐Jie Li, Wen‐Jia Zuo, Lei Ji, Yi‐Zhou Jiang, Xi‐Chun Hu, Zhong‐Hua Wang, Zhi‐Ming Shao   +7 more
doaj   +1 more source

Platelet Indices in Colorectal Cancer Patients with Synchronous Liver Metastases

Gastroenterology Research and Practice, 2019
Aims. Liver metastases occur in approximately 25% of colorectal cancer (CRC) patients and cause more than 90% of deaths in CRC. Platelets play a crucial role in cancer progression and metastases.
Li Li, Xiao-Yi Huang, Na Li, Ming-ming Cui, Rui-tao Wang   +4 more
doaj   +1 more source